GILEAD SCIENCES, INC. (GILD) 13F Holdings

Healthcare · Biological Products, (No Diagnostic Substances)

Institutional ownership and 13F holdings context for GILEAD SCIENCES, INC. (GILD) on InvestAtlant.

Top institutional holders (2026-Q3)

InstitutionSharesValue% Outstanding
GEODE CAPITAL MANAGEMENT, LLC 30,190,640 $4.49B 2.43%
Bank of New York Mellon Corp 14,756,244 $2.20B 1.19%
Amundi 11,259,657 .68B 0.91%
DEUTSCHE BANK AG\ 9,613,980 .43B 0.77%
DIMENSIONAL FUND ADVISORS LP 7,799,464 .16B 0.63%
Robeco Institutional Asset Management B.V. 3,442,819 $513.15M 0.28%
Mitsubishi UFJ Asset Management Co., Ltd. 3,346,451 $498.79M 0.27%
BARCLAYS PLC 3,141,208 $468.20M 0.25%

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.